
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
Somin-On™ is a branded ashwagandha extract standardized to not less than 2% Sominone, a biologically active withanolide uniquely derived from Ashwagandha. Clinically studied in adults with mild cognitive impairment, it supports memory, attention, and information processing. Derived from Withania somnifera, Somin-On offers consistent potency for cognitive health and mental performance.
This Technical paper is brought to you by Arjuna Natural Pvt. Ltd


Brain & Mental Health
Nootropics Depot calls for legal clarity on botanical supplement classifications and stricter testing
With a toolbox of sophisticated extract and raw material screening instruments, Nootropics Depot urges to bring botanical and mushroom composition analysis up to par with pharmaceutical-grade quality assays, which its CEO...

Brain & Mental Health
Sugary drinks may spike anxiety in adolescents, UK researchers warn
UK researchers from Bournemouth University have linked consuming highly sugary drinks to anxiety symptoms among adolescents. Anxiety disorders are a leading cause of mental distress among young people, the researchers argue. One...

Brain & Mental Health
South Korea MFDS approves Pharmactive Biotech’s saffron extract stress relief health claim
South Korea’s Ministry of Food and Drug Safety (MFDS) has officially granted Pharmactive Biotech Products individual license approval for its flagship saffron extract, Affron. The endorsement greenlights the...
Related multimedia
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement













